Fed. Circ. Upholds PTAB's Suboxone Patent Invalidation
The Federal Circuit on Wednesday affirmed the Patent Trial and Appeal Board's decision to declare Reckitt Benckiser Pharmaceuticals Inc.'s patent for the dissolvable film Suboxone, an opiate addiction treatment, invalid as...To view the full article, register now.
Already a subscriber? Click here to view full article